Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $199.3M | $219.6M | $365.9M | $419.3M | $565.1M | $559.8M | $481.7M | $484.1M |
| Cost of revenue | $16.5M | $18.6M | $174.2M | $223.8M | $281.9M | $265.7M | $238.4M | $237.2M |
| Gross profit | $182.7M | $200.9M | $191.6M | $195.6M | $283.2M | $294.1M | $243.3M | $246.8M |
| Gross margin | 91.7% | 91.5% | 52.4% | 46.6% | 50.1% | 52.5% | 50.5% | 51.0% |
| R&D | $0 | $0 | $0 | −$0 | $0 | $0 | $0 | $0 |
| Operating income | $69.4M | $77.3M | $75.4M | $21.4M | $68.9M | $65.2M | $63.0M | $59.9M |
| EBITDA | $71.4M | $79.7M | $111.1M | $103.6M | $176.9M | $135.4M | $104.3M | $92.0M |
| Net income | $45.0M | $50.8M | $38.3M | −$23.1M | $33.2M | $26.5M | −$17.8M | $1.9M |
| Net margin | 22.6% | 23.2% | 10.5% | -5.5% | 5.9% | 4.7% | -3.7% | 0.4% |
| EPS (diluted) | 0.57 | 0.63 | 0.49 | -0.29 | 0.42 | 0.33 | -0.23 | 0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $565M | $0.37 | $0.37–$0.37 | 1 |
Forward consensus · source: Financial Modeling Prep
DOVALUE SPA
No one on the platform currently holds DOVXF.
No tracked institution reports a position in DOVXF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-19 | $0.0923 | 2026-05-20 |
| Execution date | Ratio |
|---|---|
| 2024-09-23 | 1-for-5reverse |
No one on the platform has traded DOVXF yet.
| $93M |
| — |
| FISB1st Capital Bancorp | $14.00 | +0.72% | $78M | — |
| FMIAFirst Miami Bancorp, Inc. | $1400.00 | -12.50% | $122M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.